USFDA accepts regulatory submission for tanezumab for management of chronic pain due to osteoarthritis Medical Dialogues Bureau7 March 2020 10:00 AM ISTTanezumab is a monoclonal antibody that is part of an investigational class of non-opioid chronic pain medications known as nerve growth factor (NGF)...
Lower dose of Pfizer, Eli Lilly blockbuster painkiller tanezumab misses target in late stage study Farhat Nasim20 April 2019 10:00 AM ISTThe drug, tanezumab, belongs to a new category of pain medications that target nerve growth factor, a protein involved in the growth of nerve cells,...
Mediclaim for Experimental therapies-naturopathy, acupressure, acupuncture cannot be denied: Consumer Forum Meghna A Singhania14 Feb 2019 5:10 PM ISTMUMBAI: Not informing about exclusion clause to the policyholder at the time of their seeking of treatment and then denying mediclaim is the...
FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart Medical Dialogues Bureau18 Sept 2018 12:47 PM ISTSupreme court lifted the ban on the sale of Piramal Healthcare's Saridon, GlaxoSmithKline's Piriton, Juggat Pharma's Dart and another drug, banned...
